{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:56:51Z","timestamp":1791356211845,"version":"4.3.1"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"14","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,9,10]]},"DOI":"10.1097\/qad.0b013e32833ce566","type":"journal-article","created":{"date-parts":[[2010,7,12]],"date-time":"2010-07-12T06:34:42Z","timestamp":1278916482000},"page":"2211-2223","source":"Crossref","is-referenced-by-count":48,"title":["Immunogenicity and safety of an HIV-1 lipopeptide vaccine in healthy adults: a phase 2 placebo-controlled ANRS trial"],"prefix":"10.1097","volume":"24","author":[{"given":"Dominique","family":"Salmon-C\u00e9ron","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Durier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Desaint","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise","family":"Cuzin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Surenaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine Ben","family":"Hamouda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Daniel","family":"Leli\u00e8vre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9n\u00e9dicte","family":"Bonnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Pialoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Poizot-Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Aboulker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"L\u00e9vy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odile","family":"Launay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20210130","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1002\/1521-4141(200011)30:11<3256::AID-IMMU3256>3.0.CO;2-H","article-title":"Endocytosis of an HIV-derived lipopeptide into human dendritic cells followed by class I-restricted CD8+ T lymphocyte activation","volume":"30","author":"Andrieu","year":"2000","journal-title":"Eur J Immunol"},{"key":"R2-9-20210130","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1128\/JVI.77.2.1564-1570.2003","article-title":"Two human immunodeficiency virus vaccinal lipopeptides follow different cross-presentation pathways in human dendritic cells","volume":"77","author":"Andrieu","year":"2003","journal-title":"J Virol"},{"key":"R3-9-20210130","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1128\/JVI.74.4.1694-1703.2000","article-title":"Multiepitopic B- and T-cell responses induced in humans by a human immunodeficiency virus type 1 lipopeptide vaccine","volume":"74","author":"Gahery-Segard","year":"2000","journal-title":"J Virol"},{"key":"R4-9-20210130","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1097\/00002030-200107060-00005","article-title":"Lipopeptides induce cell-mediated anti-HIV immune responses in seronegative volunteers","volume":"15","author":"Pialoux","year":"2001","journal-title":"AIDS"},{"key":"R6-9-20210130","doi-asserted-by":"crossref","first-page":"e725","DOI":"10.1371\/journal.pone.0000725","article-title":"Cellular immune responses induced with dose sparing intradermal administration of HIV vaccine to HIV uninfected volunteers in the ARNS VAC 16 Trial","volume":"2","author":"Launay","year":"2007","journal-title":"PLoS One"},{"key":"R7-9-20210130","first-page":"279","article-title":"Immunological and virological efficacy of a therapeutic immunization combined with interleukin-2 in chronically HIV-1 infected patients","volume":"19","author":"L\u00e9vy","year":"2005","journal-title":"AIDS"},{"key":"R8-9-20210130","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1089\/aid.2006.22.684","article-title":"New CD4+ and CD8+ T cell responses induced in chronically HIV type-1-infected patients after immunizations with an HIV type 1 lipopeptide vaccine","volume":"22","author":"Gahery","year":"2006","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R9-9-20210130","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1128\/CVI.00165-07","article-title":"Immunological responses and long-term treatment interruption after human immunodeficiency virus type 1 (HIV-1) lipopeptide immunization of HIV-1-infected patients: the LIPTHERA study","volume":"15","author":"Pialoux","year":"2008","journal-title":"Clin Vaccine Immunol"},{"key":"R10-9-20210130","doi-asserted-by":"crossref","first-page":"11220","DOI":"10.1128\/JVI.77.20.11220-11231.2003","article-title":"Long-term specific immune responses induced in humans by a human immunodeficiency virus type 1 lipopeptide vaccine: characterization of CD8+-T-cell epitopes recognized","volume":"77","author":"Gahery-Segard","year":"2003","journal-title":"J Virol"},{"key":"R11-9-20210130","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1097\/01.aids.0000222077.68243.22","article-title":"Clinical safety of HIV lipopeptides used as vaccines in healthy volunteers and HIV-infected adults","volume":"20","author":"Durier","year":"2006","journal-title":"AIDS"},{"key":"R12-9-20210130","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0264-410X(99)00196-6","article-title":"Characterization of a multilipopeptide mixture used as an HIV-1 vaccine candidate","volume":"18","author":"Klinguer","year":"1999","journal-title":"Vaccine"},{"key":"R13-9-20210130","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jim.2005.07.014","article-title":"Monitoring of cellular responses after vaccination against tetanus toxoid: comparison of the measurement of IFN-\u03b3 production by ELISA, ELISPOT, flow cytometry and real-time PCR","volume":"305","author":"Tassignon","year":"2005","journal-title":"J Immunol Methods"},{"key":"R14-9-20210130","doi-asserted-by":"crossref","first-page":"4717","DOI":"10.1128\/JVI.80.10.4717-4728.2006","article-title":"Induction of multifunctional human immunodeficiency virus type 1 (HIV-1)-specific T cells capable of proliferation in healthy subjects by using a prime-boost regimen of DNA- and modified vaccinia virus Ankara-vectored vaccines expressing HIV-1 Gag coupled to CD8+ T-cell epitopes","volume":"80","author":"Goonetilleke","year":"2006","journal-title":"J Virol"},{"key":"R16-9-20210130","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1002\/eji.200839167","article-title":"Increased detection of proliferating, polyfunctional, HIV-1-specific T cells in DNA-modified vaccinia virus Ankara-vaccinated human volunteers by cultured IFN-gamma ELISPOT assay","volume":"39","author":"Winstone","year":"2009","journal-title":"Eur J Immunol"},{"key":"R17-9-20210130","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/S0140-6736(08)61591-3","article-title":"Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial","volume":"372","author":"Buchbinder","year":"2008","journal-title":"Lancet"},{"key":"R18-9-20210130","doi-asserted-by":"crossref","first-page":"10950","DOI":"10.1128\/JVI.01458-06","article-title":"Virus-specific cellular immune correlates of survival in vaccinated monkeys after simian immunodeficiency virus challenge","volume":"80","author":"Sun","year":"2006","journal-title":"J Virol"},{"key":"R19-9-20210130","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/nm1009","article-title":"A CD4(+) T-cell immune response to a conserved epitope in the circumsporozoite protein correlates with protection from natural Plasmodium falciparum infection and disease","volume":"10","author":"Reece","year":"2004","journal-title":"Nat Med"},{"key":"R20-9-20210130","doi-asserted-by":"crossref","first-page":"5675","DOI":"10.4049\/jimmunol.175.9.5675","article-title":"Durable human memory T cells quantifiable by cultured enzyme-linked immunospot assays are induced by heterologous prime boost immunization and correlate with protection against malaria","volume":"175","author":"Keating","year":"2005","journal-title":"J Immunol"},{"key":"R21-9-20210130","doi-asserted-by":"crossref","first-page":"4729","DOI":"10.4049\/jimmunol.167.8.4729","article-title":"Unique T cell effector functions elicited by Plasmodium falciparum in Malaria-exposed Africans tested by three T cell assays","volume":"167","author":"Flanagan","year":"2001","journal-title":"J Immunol"},{"key":"R22-9-20210130","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jim.2005.04.008","article-title":"The duration of in vitro stimulation with recall antigens determines the subset distribution of interferon-g producing lymphoid cells: a kinetic analysis using the interferon-g secretion assay","volume":"301","author":"Desombere","year":"2005","journal-title":"J Immunol Meth"},{"key":"R23-9-20210130","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nm1520","article-title":"CD8+ T-cell responses to different HIV proteins have discordant associations with viral load","volume":"13","author":"Kiepiela","year":"2007","journal-title":"Nat Med"},{"key":"R24-9-20210130","doi-asserted-by":"crossref","first-page":"e1424","DOI":"10.1371\/journal.pone.0001424","article-title":"Broad and Gag-biased HIV-1 epitope repertoires are associated with lower viral loads","volume":"3","author":"Rolland","year":"2008","journal-title":"PLoS One"},{"key":"R26-9-20210130","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa0908492","article-title":"Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand","volume":"361","author":"Rerks-Ngarm","year":"2009","journal-title":"N Engl J Med"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/QAD.0b013e32833ce566","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:30:53Z","timestamp":1786041053000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002030-201009100-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,10]]},"references-count":23,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0b013e32833ce566","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9,10]]}}}